Drug intelligence / Profile preview

VOLT-Syk

Development stage
Preclinical
Lead developer
Levolta Pharmaceuticals
Modality
Small Molecules
01

Overview

VOLT-Syk is a preclinical-stage small molecule inhibitor of spleen tyrosine kinase (Syk) being developed by Levolta Pharmaceuticals (formerly known as Volt Pharma). Syk is a non-receptor cytoplasmic tyrosine kinase that plays a pivotal role in the signaling pathways of various immune receptors, including the B-cell receptor (BCR) and Fc receptors (FcR) found on mast cells, macrophages, and neutrophils. By inhibiting Syk activity, the drug aims to disrupt the downstream inflammatory signaling cascades that lead to the activation and degranulation of these immune cells. This mechanism is intended to treat neutrophil-mediated inflammatory diseases and vasculitis, where aberrant neutrophil activation drives tissue damage and vascular inflammation. The program is currently in the preclinical phase of development.

Other names
Syk inhibitorSpleen tyrosine kinase inhibitor
02

Targets

SYK (Spleen Tyrosine Kinase)

Beyond the preview

Go deeper on VOLT-Syk.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VOLT-Syk.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call